Minimize Uncertainty – Make Informed Decisions – Succeed

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD

December 2, 2025clinical trials,Regulatory,gene editing,AATD,rare disease,biopharma,Lucid Diligence Brief,payer access,due diligence,genetic medicinesLNP delivery

Lucid Diligence Brief: Regeneron and Tessera team on TSRA-196 for AATD…

by Timos Papagatsias

Obesity Weekly News

Obesity Today—December 2, 2025

December 2, 2025wegovy,semaglutide,BioPharma and Tech News,obesity,Novo Nordisk,Eli Lilly,type 2 diabetes,Innovent Biologics,GLP-1 Receptor Agonists,Obesity NewsAmycretin,China NMPA

This week’s obesity update spotlights key developments, regulatory milestones,…

by LucidQuest

Endocrinology

Endocrinology Video Recap—December 2, 2025

December 2, 2025OBODENCE,XBRYK,Amgen,Ondibta,Sandoz,Evenity,BioPharma and Tech News,Skeletalis,diabetes,iPSC technology,osteoporosis,Cancer bone metastases,denosumab biosimilars,Theramex,Prolia,Samsung Bioepis,Xgeva,Gan and Lee,Alvotech,Pluristyx,Endocrinology News,romosozumab,OsqayJubbonti,Wyost

This biweekly endocrinology video recap highlights major shifts in bone and…

by LucidQuest

Endocrinology

Endocrinology Today—December 2, 2025

December 2, 2025BioPharma and Tech News,osteoporosistype 2 diabetes,denosumab biosimilars,Endocrinology News,prediabetes,Autism spectrum disorder,Oncology supportive care,Maternal thyroid dysfunction,Papillary thyroid cancer,AI-enabled wearables,Diabetes Prevention Program

This week’s endocrinology news delivers the latest updates, developments, and…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap —December 2, 2025

December 2, 2025Figure robot,BioPharma and Tech News,AI in Healthcare and Digital Health,Sword Health,Orchid Health,Herasight,Manhattan Genomics,Princeton University,Preventive genomics,Clinical trial simulations,Humanoid robots,Apptronik Apollo,Teva PharmaceuticalsPrefrontal cortex research,Compositionality research

Here’s your biweekly AI in Healthcare and Digital Health video brief covering…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Protego Biopharma $130M Series B

December 2, 2025clinical trials,Regulatory,rare disease,biopharma,amyloidosis,Lucid Diligence Brief,payer access,diligence,venture funding,small moleculesprotein misfolding

Lucid Diligence Brief: Protego Biopharma $130M Series B Professional audiences…

by Timos Papagatsias

Hematology

Hematology Video Recap—December 1, 2025

December 1, 2025abbvie,Bispecific Antibodies,Hemophilia A,BioPharma and Tech News,BCL2 Inhibitor,follicular lymphoma,Mantle Cell Lymphoma,BMS,Acute Myeloid Leukemia,Hematology NewsChugai Pharmaceutical,Autolus

This biweekly Hematology video recap highlights recent advancements in…

by LucidQuest

Hematology

Hematology Today—December 1, 2025

December 1, 2025ASH 2025,Bomedemstat,Hemophilia A,Nemtabrutinib,BioPharma and Tech News,Non covalent BTK inhibitor,Ziftomenib,Sonrotoclax,Mantle Cell Lymphoma,Equecabtagene autoleucel,Hemlibra,Fucaso,Emicizumab,AUCATZYL,NCCN,Breyanzi,Bristol Myers Squibb,Liso cel,Acute Myeloid Leukemia,CytoDiffusion,Hematology News,Autolus,essential thrombocythemiaPharmaEssentia,IASO Bio

This week’s hematology news covers key regulatory milestones, access decisions,…

by LucidQuest

Onco_background

Oncology Today—December 1, 2025

December 1, 2025astrazeneca,BioPharma and Tech News,Pancreatic cancer,gastric cancer,Imfinzi,Small Cell Lung Cancer,lurbinectedin,Oncology News,antibody-drug conjugates,urothelial cancergastroesophageal junction cancer,PharmaMar

This week’s oncology update highlights major regulatory milestones, late-stage…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Today—December 1, 2025

December 1, 2025Yashoda,NeuroX,takeda,MedMobile,BioPharma and Tech News,narcolepsy type 1,Microsoft,Neuraxpharm,AI in Healthcare and Digital Health,rakovina therapeutics,beacon biosignals,Sword Health,EnsoData,RadNet,DeepHealth OS,SembleNabla,Qure.ai

This week's AI in Healthcare and Digital Health update highlights…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Dayra Therapeutics, Versant Ventures and Biogen collaboration

December 1, 2025immunology,biopharma,Lucid Diligence Brief,payer access,diligence,discovery platforms,competitive landscape,regulatory path,macrocyclic peptides,venture creationVersant Ventures

Lucid Diligence Brief: Dayra Therapeutics, Versant Ventures and Biogen…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Zetagen $12.9 million Series B1 in breast cancer

November 30, 2025Oncology,clinical trials,breast cancer,biopharma,Lucid Diligence Brief,payer access,diligence,bone metastases,device pathways,SABCSinterventional radiology

Lucid Diligence Brief: Zetagen $12.9 million Series B1 in breast cancer…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.